Irritable bowel syndrome with constipation (IBS-C): Improving primary care assessment and management

May 2009
This supplement was submitted by DIME and the Duke University School of Medicine and supported by an independent educational grant from Sucampo Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc.

Irritable bowel syndrome with constipation (IBS-C) and its symptoms account 12% to 14% of primary care visits. However, due to lack of awareness by the clinician and poor patient-clinician communication, IBS-C often goes undiagnosed. This supplement seeks to raise awareness on the prevalence of IBS-C and provide clinicians with the tools to assess and manage the condition.

Take the CME test online

Full text | PDF 

CONFIDENCE BASED LEARNING

Successful Management of IBS-C in Primary Care: Barriers to Care. Patient Scenarios. Knowledge Mastery
Experience this innovative online learning experience that employs confidence based learning and learning mastery, developed with Brooks Cash, MD (Uniformed Services University of the Health Sciences) and Louis Kuritzky, MD (University of Florida). Explore the burden of care of for IBS and its subgroup of IBS-C, then reinforce these concepts in 4 patient scenarios. Earn CME hours with the ultimate goal of knowledge mastery.